Literature DB >> 11305073

Opioids in cancer pain--which one is best?

C H Wilder-Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11305073     DOI： 10.1007/s005200000228

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  4 in total

1.  Methadone in treatment of tenesmus not responding to morphine escalation.

Authors:  S Mercadante; F Fulfaro; M Dabbene
Journal:  Support Care Cancer       Date:  2001-03       Impact factor: 3.603

Review 2.  Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration.

Authors:  M P Davis; D Walsh
Journal:  Support Care Cancer       Date:  2001-03       Impact factor: 3.603

Review 3.  Hydromorphone: pharmacology and clinical applications in cancer patients.

Authors:  N Sarhill; D Walsh; K A Nelson
Journal:  Support Care Cancer       Date:  2001-03       Impact factor: 3.603

Review 4.  Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity.

Authors:  C H Wilder-Smith
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606
  4 in total
  1 in total

1.  Methadone: the question or the answer for US opioid therapy and pharmaco-economics?

Authors:  E D Dickerson
Journal:  Support Care Cancer       Date:  2001-11       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.